Are you looking for a pharma job in the UK? In this article, we’ve put together a list of the best pharma organisations to ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Revolutionizing healthcare through AI, blockchain, and interoperability, the region is setting new standards for sustainable, patient-centric care. DOHA, QA / ACCESS Newswire / January 23, 2025 / The ...

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...

DALLAS, TX / ACCESS Newswire / January 23, 2025 / Formula Wellness, a premier provider of integrated aesthetics and wellness services, is proud to formally announce Amar K. Thakrar, PharmD, MBA, as ...

As Federal Budget Cuts Threaten Healthcare Systems, RCM Vendors and Providers Strategize for Resilience WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS Newswire / January 23, 2025 / Proposed federal ...

HOUSTON, TEXAS / ACCESS Newswire / January 23, 2025 / US Med-Equip (USME) the nation's highest-rated provider of medical equipment rentals, sales, biomedical support and asset management service, ...

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESS Newswire / January 23, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based ...

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. VTT Technical Research Centre of Finland, ...

Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...